Outset Medical (OM) Net Income towards Common Stockholders (2019 - 2026)

Outset Medical (OM) has 8 years of Net Income towards Common Stockholders data on file, last reported at -$19.0 million in Q1 2026.

• On a quarterly basis, Net Income towards Common Stockholders rose 26.39% year-over-year to -$19.0 million in Q1 2026; TTM through Mar 2026 was -$74.8 million, a 34.24% increase from a year earlier, with the FY2025 full-year figure at -$81.7 million, up 36.2% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$19.0 million, up from -$19.5 million in the prior quarter.
• Over the last five years, Net Income towards Common Stockholders for OM reached as high as -$17.8 million in Q3 2025 and fell as low as -$46.2 million in Q3 2023.
• Historically, Net Income towards Common Stockholders has averaged -$33.2 million across 5 years, with a median of -$36.9 million in 2022.
• Across the five-year window, Net Income towards Common Stockholders sank 45.12% in 2022 and surged 46.19% in 2025, its largest moves.
• Year by year, Net Income towards Common Stockholders stood at -$41.4 million in 2022, then gained by 6.86% to -$38.6 million in 2023, then jumped by 33.58% to -$25.6 million in 2024, then grew by 23.98% to -$19.5 million in 2025, then gained by 2.63% to -$19.0 million in 2026.
• Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$19.0 million in Q1 2026, -$19.5 million in Q4 2025, and -$17.8 million in Q3 2025.